bpc 157 safety fda warning FDA's Overreach on Compounded Peptides BPC-157 Legal Status: FDA Regulations
Description
This upregulation correlated with reductions in adipose tissue mass

it resolved quickly and without medical intervention

doi: 10.1111/j.1444-0938.2000.tb04904.x

This establishes the peptide as a potent agent within the central and peripheral nervous systems, capable of modulating key neurotransmitter systems and facilitating recovery from injury